Exact Mass: 463.2835

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins

Bilastine

2-[4-(2-{4-[1-(2-ethoxyethyl)-1H-1,3-benzodiazol-2-yl]piperidin-1-yl}ethyl)phenyl]-2-methylpropanoic acid

C28H37N3O3 (463.2835)

R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Bilastine is a second-generation piperidine H1-antihistamine. Bilastine is a histamine H1 receptor antagonist that can be used to treat allergic rhinoconjunctivitis and urticaria.

LysoPE(P-18:1(9Z)/0:0)

(2-aminoethoxy)[(2R)-2-hydroxy-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propoxy]phosphinic acid

C23H46NO6P (463.3063)

LysoPE(P-18:1(9Z)/0:0) is a phospho-ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodelling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine, and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin and choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0, and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

Azd-4547

N-{5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl}-4-(3,5-dimethylpiperazin-1-yl)benzamide

C26H33N5O3 (463.2583)

Bucromarone

2-{4-[3-(dibutylamino)propoxy]-3,5-dimethylbenzoyl}-4H-chromen-4-one

C29H37NO4 (463.2722)

C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent

Gentamicin C2

2-[(4,6-diamino-3-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl)oxy]-5-methyl-4-(methylamino)oxane-3,5-diol

C20H41N5O7 (463.3006)

GLP-1 antagonist

BENZAMIDE, N-[[4,5-DIMETHYL-1-[(2-METHYLPHENYL)METHYL]-1H-IMIDAZOL-2-YL]METHYL]-2,4-DIMETHOXY-N-(3-METHYLBUTYL)-

C28H37N3O3 (463.2835)

Micronomicin

2-{[4,6-diamino-3-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol

C20H41N5O7 (463.3006)

Peregrine

11-ethyl-4-hydroxy-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate

C26H41NO6 (463.2934)

(3S)-4-[[(1S)-1-Carboxy-2-phenylethyl]amino]-3-[8-(diaminomethylideneamino)octanoylamino]-4-oxobutanoic acid

3-[(8-Carbamimidamido-1-hydroxyoctylidene)amino]-3-[(1-carboxy-2-phenylethyl)-C-hydroxycarbonimidoyl]propanoate

C22H33N5O6 (463.2431)

14-O-Acetyl-talatisamine

C26H41NO6 (463.2934)

Paraherquamide B

14-Demethyl-14-deoxyparaherquamide

C27H33N3O4 (463.2471)

UK 109692

11-[[4-[4-(Diethylamino)butyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-B][1,4]benzodiazepin-6-one

C27H37N5O2 (463.2947)

(2S)-(-)-2,2-OXYBIS(OCTAHYDRO-7,8,8-TRIMETHYL-4,7-METHANOBENZOFURAN)

C25H37NO5S (463.2392)

UNC 2881

C25H33N7O2 (463.2696)

Valsartan Ethyl Ester

C26H33N5O3 (463.2583)

Valsartan Ethyl Ester is an impurity of Valsartan. Valsartan is an angiotensin II receptor antagonist for the treatment of high blood pressure and heart failure[1].

(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-14-hydroxydocosa-4,7,9,11,16,19-hexaenoic acid

C25H37NO5S (463.2392)

bilastine

C28H37N3O3 (463.2835)

R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Bilastine is a histamine H1 receptor antagonist that can be used to treat allergic rhinoconjunctivitis and urticaria.

Bucromarone

C20H41N5O7 (463.3006)

Micronomicin is an antibiotic that belongs to the aminoglycoside class of organic compounds. Aminoglycosides are characterized by aminocyclitols linked to amino sugars, forming aminoglycoside antibiotics. These compounds are known for their broad-spectrum activity against various microorganisms, particularly bacteria. Micronomicin, specifically, features a structure where an aminocyclitol is connected to an amino sugar through a glycosidic bond. This structure is typical of aminoglycosides and contributes to their antimicrobial properties. The exact configuration and arrangement of atoms in micronomicin give it its specific antimicrobial profile. Micronomicin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=52093-21-7 (retrieved 2024-10-09) (CAS RN: 52093-21-7). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

C25H37NO5S (463.2392)

A docosanoid that is 17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid in which a glycinyl group is attached at position 16S via a sulfide linkage. An intermediate of specialised proresolving mediators

1-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphoethanolamine

C22H42NO7P (463.2699)

lysophosphatidylcholine 14:2

C22H42NO7P (463.2699)

A lysophosphatidylcholine in which the remaining acyl group contains 14 carbons and 2 double bonds. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.

lysophosphatidylethanolamine P-18:1

C23H46NO6P (463.3063)

A 1-(Z-alk-1-enyl)-sn-glycero-3-phosphoethanolamine in which the Z-alk-1-enyl group contains 18 carbons and has 1 additional double bond

gentamycin C2

C20H41N5O7 (463.3006)

(13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid

C25H37NO5S (463.2392)

A docosanoid that is (14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid in which a cysteinyl group is attached at position 13R via a sulfide linkage.

NA-Dopamine 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

C30H41NO3 (463.3086)

NA-Met 22:4(7Z,10Z,13Z,16Z)

C27H45NO3S (463.312)

LPC 14:2

C22H42NO7P (463.2699)

LysoPE O-18:2

benzoylnapelline